Can an Equation to Help Determine Kidney Health Be Racist?
By Jill Neimark,
Undark Magazine
| 01. 26. 2022
A reckoning in medicine has upended the use of race in calculating kidney function, spurring institutional change.
"creatinine" by Lori Greig is licensed under CC 2.0
On the morning of June 19, 2020—Juneteenth, now a federal holiday — students in the Internal Medicine Residency Program at the University of California, Davis gathered for weekly rounds. Rachael Lucatorto, the associate program director, opened the session by playing a recording of the Emancipation Proclamation. She then jumpstarted a discussion about racism in medicine.
For Bisrat Woldemichael, then a fourth year medical student at UC Davis and now a resident at Emory University, it was a chance to speak about racism in kidney care, or nephrology. Black Americans experience kidney failure nearly four times as often as White Americans. And yet they are less likely to receive timely referrals to a specialist.
One big problem, Woldemichael remembers pointing out that June morning, was that a common tool for measuring kidney health factored in race. “Racism is very obviously present in a lot of ‘objective’ data in medicine,” she says. Many equations and guidelines adjust for race, and while it is sometimes a convenient proxy, critics say...
Related Articles
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Sayantani DasGupta, MedPage Today | 08.05.2025
It's just a jeans ad.
It's not that deep.
It's just social media outrage.
Should physicians care about the recent American Eagle "Sydney Sweeney Has Good Genes Jeans" controversy? What, if anything, does the provocative campaign have to...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...